Pharmacists Can Help Address Treatment Challenges for Patients With Cholangiocarcinoma
Treatment options can be limited for this patient population.
Stay updated with breaking news from Rose Dimarco. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Treatment options can be limited for this patient population.
With their final thoughts, the panelists provide key takeaways from their conversation regarding CDK4/6 inhibitor therapy in treatment of HR+/HER2- metastatic breast cancer.
Drs DiMarco and Moore weigh the benefits and barriers associated with clinical pathways in treating patients with mBC.
Medical experts weigh in on the strength of collaborative care and shared decision-making in the management of metastatic breast cancer (mBC).
Expert panelists discuss the impact of CDK4/6 inhibitor therapy on progression-free and overall survival.